Phase I study with weekly Paclitaxel (1 H) infusion in heavily pretreated advanced breast cancer and ovarian cancer patients

被引：0
|
作者：
Klaassen, U [1 ]
Wilke, H [1 ]
Strumberg, D [1 ]
Eberhardt, W [1 ]
Korn, M [1 ]
Seeber, S [1 ]
机构：
[1] UNIV ESSEN GESAMTHSCH,W GERMAN CANC CTR,DEPT INTERNAL MED CANC RES,ESSEN,GERMANY
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：380 / 380
页数：1
相关论文
共 50 条
  • [41] A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer
    Fornier, M. N.
    Morris, P. G.
    Abbruzzi, A.
    D'Andrea, G.
    Gilewski, T.
    Bromberg, J.
    Dang, C.
    Dickler, M.
    Modi, S.
    Seidman, A. D.
    Sklarin, N.
    Chang, J.
    Norton, L.
    Hudis, C. A.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (12) : 2575 - 2581
  • [42] First-line chemotherapy with weekly paclitaxel and carboplatin for advanced ovarian cancer: A phase I study
    Sehouli, J
    Stengel, D
    Elling, D
    Ortmann, O
    Blohmer, J
    Riess, H
    Lichtenegger, W
    [J]. GYNECOLOGIC ONCOLOGY, 2002, 85 (02) : 321 - 326
  • [43] Weekly paclitaxel in elderly patients with advanced breast cancer
    Reperto, L
    Comandini, D
    Hazini, A
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 47 - 47
  • [44] Phase I–II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines
    Patrizia Vici
    Alessandra Fabi
    Giulio Metro
    Domenico Sergi
    Diana Giannarelli
    Luigi Di Lauro
    Gerold Bepler
    Federica Tomao
    Francesco Cognetti
    Francesca Conti
    Massimo Lopez
    [J]. Cancer Chemotherapy and Pharmacology, 2011, 67 : 687 - 693
  • [45] Vinorelbine induced neurotoxicity in patients with advanced breast cancer pretreated with paclitaxel - A phase II study
    Fazeny, B
    Zifko, U
    Meryn, S
    Huber, H
    Grisold, W
    Dittrich, C
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 39 (1-2) : 150 - 156
  • [46] Weekly docetaxel in pretreated metastatic breast cancer patients:: A phase I-II study
    Nisticò, C
    Cognetti, F
    Frontini, L
    Barni, S
    Ferretti, G
    Bria, E
    Milella, M
    Garufi, C
    Cuppone, F
    Vanni, B
    Carlini, P
    Terzoli, E
    [J]. ONCOLOGY, 2005, 68 (4-6) : 356 - 363
  • [47] Platelet-sparing effect of paclitaxel in heavily pretreated ovarian cancer patients
    Ishikawa H.
    Fujiwara K.
    Suzuki S.
    Tanaka Y.
    Kohno I.
    [J]. International Journal of Clinical Oncology, 2002, 7 (5) : 330 - 333
  • [48] Weekly paclitaxel in patients with recurrent or persistent advanced ovarian cancer
    Ghamande, S
    Lele, S
    Marchetti, D
    Baker, T
    Odunsi, K
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (02) : 142 - 147
  • [49] A phase I study -: UFT/leucovorin combined with paclitaxel for anthracycline-pretreated advanced breast cancer
    Scholz, U
    Lück, HJ
    Canzler, U
    Robner, D
    Kühnle, H
    [J]. ONCOLOGY-NEW YORK, 2000, 14 (10): : 44 - 46
  • [50] Phase I study with paclitaxel in combination with ifosfamide in pretreated patients with advanced ovarian carcinoma
    Klaassen, U
    Harstrick, A
    Stahl, M
    Eberhardt, W
    Korn, M
    Strumberg, D
    Becher, R
    Wilke, H
    Seeber, S
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 504 - 504
12345